Rapid diagnostic test evaluation in the Democratic Republic of the Congo, part of the BRIDGE Dx Access initiative (provisional wording)

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    Ebola
  • Start & end year

    2026
  • Known Financial Commitments (USD)

    $1,691,046
  • Funder

    Foreign, Commonwealth & Development Office (FCDO)
  • Research Location

    Congo (DRC)
  • Lead Research Institution

    PATH
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics
  • Research Subcategory

    Diagnostics
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

FCDO grant to PATH for a diagnostics validation initiative with WHO and other partners, focused on evaluating rapid diagnostic tests in the Democratic Republic of the Congo during the 2026 Bundibugyo virus disease outbreak.